Author

R. Issa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

B. Ciani· 1 shared C. E. Turner· 1 shared F. Albaldi· 1 shared H. Khalid· 1 shared K. Kostarelos· 1 shared L. J. Partridge· 1 shared L. R. Green· 1 shared L. Urwin· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Ciani

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Functioning human lung organoids model pulmonary tissue response from carbon nanomaterial exposures

R. Issa, N. Lozano, K. Kostarelos, S. Vranic

This study uses human lung organoids to model pulmonary responses to carbon nanomaterials, showing MWCNTs cause pro-fibrotic effects while GO does not.

bioRxiv · Mar 30, 2023Pharmacology & Toxicology

CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway

L. R. Green, R. Issa, F. Albaldi, L. Urwin, H. Khalid, C. E. Turner, B. Ciani, L. J. Partridge, P. N. Monk

This study shows CD9 and syndecan-1 cooperate for staphylococcal adhesion, with fibronectin also playing a role, and suggests CD9-targeted therapies could block bacterial entry.

bioRxiv · Jan 17, 2023Microbiology